Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374719 · ClinicalTrials.gov registry record
WiTNNess - TNNT1 Myopathy Natural History Study
A clinical trial of Myopathy and TNNT1-associated Myopathy, sponsored by Clinic for Special Children.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06374719: Recruiting study of Myopathy and TNNT1-associated Myopathy, sponsored by Clinic for Special Children.
NCT06374719 is a study of Myopathy and TNNT1-associated Myopathy that is actively recruiting participants, run by Clinic for Special Children. The registered enrollment target is 40 participants, roughly in line with the 41-participant average among 3 other Myopathy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06374719, a study of Myopathy and TNNT1-associated Myopathy, is actively recruiting participants, sponsored by Clinic for Special Children.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Participants can choose to include their information once (cross-sectional cohort) or every few months (prospective cohort).
Primary Outcome
The primary outcome is time until death or permanent ventilatory support, defined as any invasive (e.g., tracheostomy) or non-invasive (e.g., bilevel positive airway pressure) mechanical ventilatory assistance for ≥16 hours daily during ≥14 consecutive days in the absence of a reversible clinical state.
Conditions Studied
Study Locations (1)
Pennsylvania
- Clinic for Special Children - Gordonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-09-23 |
| Est. Completion | 2027-06-01 |
What NCT06374719 shows while recruiting
NCT06374719 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, roughly in line with the 41-participant average among 3 other Myopathy trials with a reported enrollment target.
The record links to 10 conditions, with Myopathy appearing as the primary indexed condition, and to 0 interventions.
NCT06374719 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06374719 about?
NCT06374719 is a clinical study titled "WiTNNess - TNNT1 Myopathy Natural History Study". WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Partici...
What is the current status of trial NCT06374719?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2018-09-23. Estimated completion is 2027-06-01.
What conditions does trial NCT06374719 study?
This clinical trial studies the following conditions: Myopathy, TNNT1-associated Myopathy, Infantile-onset Nemaline Rod Myopathy, Myopathies, Nemaline, Myopathy, Rod.
Who is sponsoring clinical trial NCT06374719?
This trial is sponsored by Clinic for Special Children, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374719 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
RECRUITING
-
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
ACTIVE NOT RECRUITING · NA
-
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI